Develops RNA-based therapeutics for serious & life-threatening rare & infectious diseases.
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2014 | SQUIRE PATTON BOGGS |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Termination (No Activity) |
— | |
| 2014 | SQUIRE PATTON BOGGS |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | |
| 2014 | SQUIRE PATTON BOGGS |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | |
| 2014 | SQUIRE PATTON BOGGS |
1st Quarter (Jan 1 - Mar 31) Registration |
— |
| Firm | Filings | Expenses |
|---|---|---|
| SQUIRE PATTON BOGGS | 4 | — |
| Issue | Activities |
|---|---|
| Health Issues | 3 |